Information about Pharma Poperinge
My details
*
*
*

Pharma Poperinge (SRL)

BE 0756.924.553

Voskenslaan 399, 9000 Gent

Company information

Status
Active

Enterprise number

BE0756.924.553

VAT liability
Yes
Established
23-10-2020
Last balance sheet year
2025
Company size
Small 0,7 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharma Poperinge

2025 2024 2023 2022
Profit/Loss € 182,985 -12,31% € 208,662 38,28% € 150,898 -12,53% € 172,514
Equity € 43,854 -94,14% € 748,869 38,63% € 540,207 38,76% € 389,309
Gross margin € 298,760 -20,91% € 377,726 28,45% € 294,066 -6,74% € 315,318
Employees 0.7 1.5 1.5 1.5

Publications from Pharma Poperinge

Date Publication
27-10-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Pharma Poperinge?
The VAT number of Pharma Poperinge is BE 0756.924.553.
Wat is the PEPPOL ID of Pharma Poperinge?
The PEPPOL ID of Pharma Poperinge is 0208:0756924553. Log in or start a free trial to see the full overview.
When was Pharma Poperinge founded?
Pharma Poperinge was founded on 23-10-2020.
What is the address of Pharma Poperinge?
The current registered office of Pharma Poperinge is located at Voskenslaan 399, 9000 Gent.
When was the last time Pharma Poperinge filed their annual financial statements?
The most recent financial statements of Pharma Poperinge were filed on 23-07-2026.
How many employees does Pharma Poperinge have?
There are 0,7 FTEs working at Pharma Poperinge according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharma Poperinge?
At the time of its most recent financial statements, Pharma Poperinge did not publish any turnover figures. Pharma Poperinge reported a gross margin of €298,760.13.

Sources